Veterinary Medicines

HATCHPAK IB H120 NEO effervescent tablet for nebuliser suspension for chickens

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Download as PDF

Product identification

Medicine name:
HATCHPAK IB H120 NEO EFFERVESCENT TABLET FOR OCULONASAL SUSPENSION FOR CHICKENS
HATCHPAK IB H120 NEO effervescent tablet for nebuliser suspension for chickens
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken (one day-old chick)
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.70
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (one day-old chick)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Box of 1 blister of 10 tablets of 2,000 doses
  • Box of 10 blisters of 10 tablets of 1,000 doses
  • Box of 10 blisters of 10 tablets of 2,000 doses
  • Box of 1 blister of 10 tablets of 1,000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/061/001
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0171/002
Concerned member states:
  • Belgium
  • Cyprus
  • Denmark
  • Finland
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Netherlands
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."